UK MHRA to recognise medicine approvals including from FDA and EMA!!!
So, who is going to monitor safety of the supply chains?
Massive shout out
We begin with a massive shout out to Cheryl Grainger (Twitter handle ) and Debi Evans (UK Column Blog) for unearthing this little bombshell:
UK MHRA to recognise medicine approvals including from FDA and EMA
“The new recognition routes will provide a fast-track UK application process for products already licensed in the trusted partner markets listed above, with the MHRA retaining responsibility for approving such accelerated applications. The new routes will build on the MHRA’s existing European Commission (EC) Decision Reliance Procedure, which enables marketing authorisation applications for Great Britain to be based on the European Commission’s decision to grant an EU centralised marketing authorisation and the applicant to receive an accelerated decision from the MHRA within 67 days or less. It also complements the UK national authorisation process and accelerated access route, the Innovative Licensing and Access Pathway (ILAP).”
Remember this?:
Debi Evans, Nursing Correspondent, UK Column, keeps turning up shocking stuff!
Debi Evans Many of you will know Debi who writes a facinating Blog for UK Column, and does tons of excellent interviews. This is her blog for this month: Debi Evans Blog: 6 June 2023 Every week we exchange text messages and each time I learn something new emerging from her latest investigative excursions to the dark side. This week has been no exception, and her latest revelation joins up more dots to the dots already connected previously.
Quote: “Background
The government has set out an ambition to cement the UK’s position as a science superpower with a series of new commitments. The creation of ARIA will complement the work of UK Research and Innovation (UKRI) while building on the government’s ambitious R&D Roadmap published in July 2020.
In November 2020, the Spending Review set out the government’s plan to invest £14.6 billion in R&D in 2021 to 2022, building towards the government’s target of 2.4% of GDP being spent on R&D across the UK economy by 2027, the current OECD average. Achieving this ambition will drive long-term economic growth, support the UK’s position as a global force in science and innovation, and create wider benefits for society.”
Keeping on banging the drum
Folks, please, you’ve got to believe me—UK Government (and MHRA) is working hand in glove with Big Pharma, the Bill & Melinda Gates Foundation, plus other evil actors. Whether you think these are bioweapons, or not, this is being coordinated globally from the UK.